Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoko Matsui

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Tumori|October 3, 2015
Lactate dehydrogenase and body mass index are prognostic factors in patients with recurrent small cell lung cancer receiving amrubicinMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
The Journal of International Medical Research|May 31, 2015
Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective studyKensuke Suzuki, Hideaki Furuse, Takeshi Tsuda, et al.
FEBS Letters|July 18, 2006
Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activationToru Yamada, Muneharu Maruyama, Tadashi Fujita, et al.
Modern Rheumatology|December 19, 2017
Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related diseaseTomohiro Handa, Shoko Matsui, Hajime Yoshifuji, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI TherapyMinehiko Inomata, Kenji Azechi, Naoki Takata, et al.
Tumori|October 25, 2014
Outcome and prognostic factors in patients with small cell lung cancer who receive third-line chemotherapyMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Medical Oncology (Northwood, London, England)|August 11, 2014
Usefulness of the Palliative Prognostic Index in patients with lung cancerMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Journal of Medical Case Reports|September 6, 2012
Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case reportMinehiko Inomata, Ryuji Hayashi, Kenta Kambara, et al.
Internal Medicine (Tokyo, Japan)|August 8, 2020
Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung CancerMinehiko Inomata, Takahiro Hirai, Naoki Takata, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 ExpressionMinehiko Inomata, Naoki Takata, Isami Mizushima, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Tumori|October 3, 2015
Lactate dehydrogenase and body mass index are prognostic factors in patients with recurrent small cell lung cancer receiving amrubicinMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
The Journal of International Medical Research|May 31, 2015
Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective studyKensuke Suzuki, Hideaki Furuse, Takeshi Tsuda, et al.
FEBS Letters|July 18, 2006
Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activationToru Yamada, Muneharu Maruyama, Tadashi Fujita, et al.
Modern Rheumatology|December 19, 2017
Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related diseaseTomohiro Handa, Shoko Matsui, Hajime Yoshifuji, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI TherapyMinehiko Inomata, Kenji Azechi, Naoki Takata, et al.
Tumori|October 25, 2014
Outcome and prognostic factors in patients with small cell lung cancer who receive third-line chemotherapyMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Medical Oncology (Northwood, London, England)|August 11, 2014
Usefulness of the Palliative Prognostic Index in patients with lung cancerMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Journal of Medical Case Reports|September 6, 2012
Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case reportMinehiko Inomata, Ryuji Hayashi, Kenta Kambara, et al.
Internal Medicine (Tokyo, Japan)|August 8, 2020
Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung CancerMinehiko Inomata, Takahiro Hirai, Naoki Takata, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 ExpressionMinehiko Inomata, Naoki Takata, Isami Mizushima, et al.
Pageof 9